1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Wakimoto R, Ono M, Takeshima M, Higuchi T
and Nakano S: Differential anticancer activity of pterostilbene
against three subtypes of human breast cancer cells. Anticancer
Res. 37:6153–6159. 2017.PubMed/NCBI
|
3
|
Chavoshi H, Vahedian V, Saghaei S,
Pirouzpanah MB, Raeisi M and Samadi N: Adjuvant therapy with
silibinin improves the efficacy of paclitaxel and cisplatin in
MCF-7 breast cancer cells. Asian Pac J Cancer Prev. 18:2243–2247.
2017.PubMed/NCBI
|
4
|
Zhao Y, Tian B, Wang Y and Ding H:
Kaempferol sensitizes human ovarian cancer cells-OVCAR-3 and SKOV-3
to tumor necrosis factor-related apoptosis-inducing ligand
(TRAIL)-induced apoptosis via JNK/ERK-CHOP pathway and
up-regulation of death receptors 4 and 5. Med Sci Monit.
23:5096–5105. 2017. View Article : Google Scholar : PubMed/NCBI
|
5
|
Wu WS, Chien CC, Liu KH, Chen YC and Chiu
WT: Evodiamine prevents glioma growth, induces glioblastoma cell
apoptosis and cell cycle arrest through JNK activation. Am J Chin
Med. 45:879–899. 2017. View Article : Google Scholar : PubMed/NCBI
|
6
|
Bi Y, Zhu Y, Zhang M, Zhang K, Hua X, Fang
Z, Zhou J, Dai W, Cui Y, Li J, et al: Effect of shikonin on spinal
cord injury in rats via regulation of HMGB1/TLR4/NF-kB signaling
pathway. Cell Physiol Biochem. 43:481–491. 2017. View Article : Google Scholar : PubMed/NCBI
|
7
|
Ding H, Jiang L, Xu J, Bai F, Zhou Y, Yuan
Q, Luo J, Zen K and Yang J: Inhibiting aerobic glycolysis
suppresses renal interstitial fibroblast activation and renal
fibrosis. Am J Physiol Renal Physiol. 313:F561–F575. 2017.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Andújar I, Ríos JL, Giner RM and Recio MC:
Pharmacological properties of shikonin-a review of literature since
2002. Planta Med. 79:1685–1697. 2013. View Article : Google Scholar : PubMed/NCBI
|
9
|
Yang Y, Wang J, Yang Q, Wu S, Yang Z, Zhu
H, Zheng M, Liu W, Wu W, He J, et al: Shikonin inhibits the
lipopolysaccharide-induced release of HMGB1 in RAW264.7 cells via
IFN and NF-κB signaling pathways. Int Immunopharmacol. 19:81–87.
2014. View Article : Google Scholar : PubMed/NCBI
|
10
|
Wang SY, Yang XJ, Yang SS, Wang W, Tian
YY, Cao FL and Zhou J: Association analysis of cytokine
polymorphisms and plasma level in Northern Chinese Han patients
with paroxysmal nocturnal hemoglobinuria. Chin Med J (Engl).
125:1576–1580. 2012.PubMed/NCBI
|
11
|
Chen Y, Zheng L, Liu J, Zhou Z, Cao X, Lv
X and Chen F: Shikonin inhibits prostate cancer cells metastasis by
reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and
ROS/ERK1/2 pathways. Int Immunopharmacol. 21:447–455. 2014.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Ning L, Ma H, Jiang Z, Chen L, Li L, Chen
Q and Qi H: Curcumol suppresses breast cancer cell metastasis by
inhibiting MMP-9 via JNK1/2 and Akt-dependent NF-κB signaling
pathways. Integr Cancer Ther. 15:216–225. 2016. View Article : Google Scholar : PubMed/NCBI
|
13
|
Scherberich A, Tucker RP, Degen M,
Brown-Luedi M, Andres AC and Chiquet-Ehrismann R: Tenascin-W is
found in malignant mammary tumors, promotes alpha8
integrin-dependent motility and requires p38MAPK activity for BMP-2
and TNF-alpha induced expression in vitro. Oncogene. 24:1525–1532.
2005. View Article : Google Scholar : PubMed/NCBI
|
14
|
Su Y, Huang N, Chen D, Zhang L, Dong X,
Sun Y, Zhu X, Zhang F, Gao J, Wang Y, et al: Successful in vivo
hyperthermal therapy toward breast cancer by Chinese medicine
shikonin-loaded thermosensitive micelle. Int J Nanomedicine.
12:4019–4035. 2017. View Article : Google Scholar : PubMed/NCBI
|
15
|
Jang SY, Lee JK, Jang EH, Jeong SY and Kim
JH: Shikonin blocks migration and invasion of human breast cancer
cells through inhibition of matrix metalloproteinase-9 activation.
Oncol Rep. 31:2827–2833. 2014. View Article : Google Scholar : PubMed/NCBI
|
16
|
Jiang W, Tian W, Ijaz M and Wang F:
Inhibition of EGF-induced migration and invasion by sulfated
polysaccharide of Sepiella maindroni ink via the suppression of
EGFR/Akt/p38 MAPK/MMP-2 signaling pathway in KB cells. Biomed
Pharmacother. 95:95–102. 2017. View Article : Google Scholar : PubMed/NCBI
|
17
|
Thakur R, Trivedi R, Rastogi N, Singh M
and Mishra DP: Inhibition of STAT3, FAK and Src mediated signaling
reduces cancer stem cell load, tumorigenic potential and metastasis
in breast cancer. Sci Rep. 5:101942015. View Article : Google Scholar : PubMed/NCBI
|
18
|
Nie Y, Yang Y, Zhang J, Cai G, Chang Y,
Chai G and Guo C: Shikonin suppresses pulmonary fibroblasts
proliferation and activation by regulating Akt and p38 MAPK
signaling pathways. Biomed Pharmacother. 95:1119–1128. 2017.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Takaku S, Shimizu M and Takahashi H:
Japanese Kampo medicine ninjin'yoeito synergistically enhances
tumor vaccine effects mediated by CD8+ T cells. Oncol
Lett. 13:3471–3478. 2017. View Article : Google Scholar : PubMed/NCBI
|
20
|
Borhani S, Mozdarani H, Babalui S,
Bakhshandeh M and Nosrati H: In vitro radiosensitizing effects of
temozolomide on U87MG cell lines of human glioblastoma multiforme.
Iran J Med Sci. 42:258–265. 2017.PubMed/NCBI
|
21
|
Hsu PC, Huang YT, Tsai ML, Wang YJ, Lin JK
and Pan MH: Induction of apoptosis by shikonin through coordinative
modulation of the Bcl-2 family, p27, and p53, release of cytochrome
c, and sequential activation of caspases in human colorectal
carcinoma cells. J Agric Food Chem. 52:6330–6337. 2004. View Article : Google Scholar : PubMed/NCBI
|
22
|
Nam KN, Son MS, Park JH and Lee EH;
Shikonins attenuate microglial inflammatory responses by inhibition
of ERK, Akt, and NF-kappa B, : Neuroprotective implications.
Neuropharmacology. 55:819–825. 2008. View Article : Google Scholar : PubMed/NCBI
|
23
|
Baradaran PC, Mohammadi A, Mansoori B,
Baradaran SC and Baradaran B: Growth inhibitory effect of
Scrophularia oxysepala extract on mouse mammary carcinoma 4T1 cells
in vitro and in vivo systems. Biomed Pharmacother. 85:718–724.
2017. View Article : Google Scholar : PubMed/NCBI
|
24
|
Gong K and Li W: Shikonin, a Chinese
plant-derived naphthoquinone, induces apoptosis in hepatocellular
carcinoma cells through reactive oxygen species: A potential new
treatment for hepatocellular carcinoma. Free Radic Biol Med.
51:2259–2271. 2011. View Article : Google Scholar : PubMed/NCBI
|
25
|
Mao X, Yu CR, Li WH and Li WX: Induction
of apoptosis by shikonin through a ROS/JNK-mediated process in
Bcr/Abl-positive chronic myelogenous leukemia (CML) cells. Cell
Res. 18:879–888. 2008. View Article : Google Scholar : PubMed/NCBI
|
26
|
Liu T, Xia Y, Li J, Li S, Feng J, Wu L,
Zhang R, Xu S, Cheng K, Zhou Y, et al: Shikonin attenuates
concanavalin A-induced acute liver injury in mice via inhibition of
the JNK pathway. Mediators Inflamm 2016. 27483672016.
|
27
|
Kim KY, Park KI, Kim SH, Yu SN, Park SG,
Kim YW, Seo YK, Ma JY and Ahn SC: Inhibition of autophagy promotes
salinomycin-induced apoptosis via reactive oxygen species-Mediated
PI3K/AKT/mTOR and ERK/p38 MAPK-dependent signaling in human
prostate cancer cells. Int J Mol Sci. 18:10882017. View Article : Google Scholar :
|
28
|
Yoshida K, Kuwano K, Hagimoto N, Watanabe
K, Matsuba T, Fujita M, Inoshima I and Hara N: MAP kinase
activation and apoptosis in lung tissues from patients with
idiopathic pulmonary fibrosis. J Pathol. 198:388–396. 2002.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Khalil N, Xu YD, O'Connor R and Duronio V:
Proliferation of pulmonary interstitial fibroblasts is mediated by
transforming growth factor-beta1-induced release of extracellular
fibroblast growth factor-2 and phosphorylation of p38 MAPK and JNK.
J Biol Chem. 280:43000–43009. 2005. View Article : Google Scholar : PubMed/NCBI
|
30
|
Ahn J, Won M, Choi JH, Kim YS, Jung CR, Im
DS, Kyun ML, Lee K, Song KB and Chung KS: Reactive oxygen
species-mediated activation of the Akt/ASK1/p38 signaling cascade
and p21(Cip1) downregulation are required for shikonin-induced
apoptosis. Apoptosis. 18:870–881. 2013. View Article : Google Scholar : PubMed/NCBI
|
31
|
Shahsavari Z, Karami-Tehrani F and Salami
S: Shikonin induced necroptosis via reactive oxygen species in the
T-47D breast cancer cell line. Asian Pac J Cancer Prev.
16:7261–7266. 2015. View Article : Google Scholar : PubMed/NCBI
|
32
|
Lan W, Wan S, Gu W, Wang H and Zhou S:
Mechanisms behind the inhibition of lung adenocarcinoma cell by
shikonin. Cell Biochem Biophys. 70:1459–1467. 2014. View Article : Google Scholar : PubMed/NCBI
|
33
|
Nguyen QD, Challapalli A, Smith G, Fortt R
and Aboagye EO: Imaging apoptosis with positron emission
tomography: ‘bench to bedside’ development of the caspase-3/7
specific radiotracer [(18)F]ICMT-11. Eur J Cancer. 48:432–440.
2012. View Article : Google Scholar : PubMed/NCBI
|
34
|
Hong D, Jang SY, Jang EH, Jung B, Cho IH,
Park MJ, Jeong SY and Kim JH: Shikonin as an inhibitor of the
LPS-induced epithelial-to-mesenchymal transition in human breast
cancer cells. Int J Mol Med. 36:1601–1606. 2015. View Article : Google Scholar : PubMed/NCBI
|